Literature DB >> 24497337

Ultrasound-assisted thrombolysis for acute pulmonary embolism: a systematic review.

Rolf P Engelberger1, Nils Kucher.   

Abstract

Pulmonary embolism remains a common and potentially life-threatening disease. For patients with intermediate- and high-risk pulmonary embolism, catheter-based revascularization therapy has emerged as potential alternative to systemic thrombolysis or surgical embolectomy. Ultrasound-assisted catheter-directed thrombolysis is a contemporary catheter-based technique and is the focus of the present review. Ultrasound-assisted catheter-directed thrombolysis is more effective in reversing right ventricular dysfunction and dilatation in comparison with anticoagulation alone in patients at intermediate risk. However, a direct comparison of ultrasound-assisted thrombolysis with systemic thrombolysis or surgical thrombectomy is not available. Ultrasound-assisted thrombolysis with initial intrapulmonary thrombolytic bolus may also be effective in high-risk patients, but evidence from randomized trials is not available. This review summarizes current data on ultrasound-assisted thrombolysis for acute pulmonary embolism.

Entities:  

Keywords:  Bleeding; Catheter-based revascularization; Pulmonary embolism; Ultrasound-assisted thrombolysis

Mesh:

Substances:

Year:  2014        PMID: 24497337     DOI: 10.1093/eurheartj/ehu029

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

1.  Catheter-Directed Interventions for Acute Pulmonary Embolism: The Jury Is Still Out.

Authors:  Nathan L Liang; Rabih A Chaer; Efthymios D Avgerinos
Journal:  Chest       Date:  2015-09       Impact factor: 9.410

2.  Regional and Conducted Vascular Effects of Endovascular Ultrasound Catheters.

Authors:  Matthew A Muller; Aris Xie; Yue Qi; Yan Zhao; Koya Ozawa; Misty Noble-Vranish; Jonathan R Lindner
Journal:  Ultrasound Med Biol       Date:  2020-06-08       Impact factor: 2.998

3.  Comparative Outcomes of Ultrasound-Assisted Thrombolysis and Standard Catheter-Directed Thrombolysis in the Treatment of Acute Pulmonary Embolism.

Authors:  Nathan L Liang; Efthymios D Avgerinos; Luke K Marone; Michael J Singh; Michel S Makaroun; Rabih A Chaer
Journal:  Vasc Endovascular Surg       Date:  2016-08       Impact factor: 1.089

4.  Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared with catheter-directed intervention for the treatment of acute pulmonary embolism.

Authors:  Nathan L Liang; Efthymios D Avgerinos; Michael J Singh; Michel S Makaroun; Rabih A Chaer
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2017-01-16

Review 5.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 6.  [Diagnostics of acute pulmonary embolism : An update].

Authors:  M Das; J E Wildberger
Journal:  Radiologe       Date:  2016-06       Impact factor: 0.635

Review 7.  [Pulmonary embolism].

Authors:  M Hecker; N Sommer; A Hecker; D Bandorski; M A Weigand; G A Krombach; E Mayer; D Walmrath
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-11-30       Impact factor: 0.840

Review 8.  Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism.

Authors:  Matthew A Chiarello; Akhilesh K Sista
Journal:  Semin Intervent Radiol       Date:  2018-06-04       Impact factor: 1.513

Review 9.  Endovascular Management of Massive and Submassive Acute Pulmonary Embolism: Current Trends in Risk Stratification and Catheter-Directed Therapies.

Authors:  Ethan C Kosova; Kush R Desai; Daniel R Schimmel
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

10.  Catheter-directed ultrasound-accelerated thrombolysis may be life-saving in patients with massive pulmonary embolism after failed systemic thrombolysis.

Authors:  Saim Sag; Omer Fatih Nas; Aysel Aydin Kaderli; Bulent Ozdemir; İbrahim Baran; Cuneyt Erdoğan; Sumeyye Gullulu; Bahattin Hakyemez; Ali Aydinlar
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.